Thought Leadership & Other Media

Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy

Events Thought Leadership Cell & Gene Therapy

Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020. 

Article: Process Development: How to Win the Race in Cell & Gene Therapy

Thought Leadership Cell & Gene Therapy

In this spotlight article, presented by BioInsights, Dr. Ramin Baghirzade, AGC Biologics' Global Head of Business Development for Cell & Gene Therapy, shares his expert insights on the state of the industry, and four inter-connected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.

Follow Us
Join us on LinkedIn Follow us on Twitter